» Articles » PMID: 10548823

Classification of Osteoporosis and Osteopenia in Postmenopausal Women is Dependent on Site-specific Analysis

Overview
Journal J Clin Densitom
Date 1999 Nov 5
PMID 10548823
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the availability of guidelines from the World Health Organization study group for the classification of osteoporosis in postmenopausal Caucasian women, confusion still exists about the number of sites used for diagnosis and the clinical utility of peripheral bone mass assessments. To examine the diagnosis of osteoporosis and osteopenia based on bone density measurements at single or multiple sites using central and peripheral measurements, we studied 115 ambulatory, community-dwelling, Caucasian postmenopausal women. Bone mineral density of the hip, PA spine, forearm, and finger were assessed by dual X-ray absorptiometry. Bone mass of the calcaneus was obtained using ultrasound. The diagnosis of osteoporosis based on a single measurement varied from 4% using the trochanteric region to 34% using Ward's triangle, 17% using the calcaneus, and 13% using the finger. Twenty-eight percent of the women had osteoporosis if the diagnosis was based on at least one osteoporotic value at three standard central sites (PA spine, total hip, femoral neck). Among these women, using T-scores provided by the manufacturers, 16% of osteoporotic patients would be misclassified as normal using the Sahara Clinical Bone Sonometer (Hologic, Waltham, MA) (heel) and 34% misclassified using the accuDEXA (Schick, New York, NY) (finger). We conclude that there is significant variability in the classification of osteoporosis based on site selection, with significant potential for misdiagnosis.

Citing Articles

Denosumab for osteoporosis in older adults in long-term care: A randomized trial.

Greenspan S, Perera S, Haeri N, Nace D, Resnick N J Am Geriatr Soc. 2024; 73(2):445-457.

PMID: 39523676 PMC: 11828690. DOI: 10.1111/jgs.19260.


Zoledronic acid and bone health in older adults with cognitive impairment.

Churilla B, Perera S, Greenspan S, Resnick N, Kotlarczyk M Osteoporos Int. 2021; 33(1):293-298.

PMID: 34341833 PMC: 8758516. DOI: 10.1007/s00198-021-06063-6.


Optimising the management of osteoporosis.

Farrah Z, Jawad A Clin Med (Lond). 2020; 20(5):e196-e201.

PMID: 32934064 PMC: 7539745. DOI: 10.7861/clinmed.2020-0131.


Early changes in bone turnover predict longer-term changes in bone mineral density but not trabecular bone score in frail older women.

Kotlarczyk M, Perera S, Resnick N, Nace D, Greenspan S Arch Osteoporos. 2020; 15(1):79.

PMID: 32458096 PMC: 8006805. DOI: 10.1007/s11657-020-00749-w.


Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.

Greenspan S, Vujevich K, Britton C, Herradura A, Gruen G, Tarkin I Osteoporos Int. 2017; 29(2):501-506.

PMID: 29085957 PMC: 6468986. DOI: 10.1007/s00198-017-4286-7.